24th Nov 2016 07:30
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
|
| |||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | GW Pharmaceuticals PLC | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights |
| |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | x | |||
An event changing the breakdown of voting rights |
| |||
Other (please specify): |
|
| ||
3. Full name of person(s) subject to thenotification obligation: iii | The Goldman Sachs Group, Inc. | |||
4. Full name of shareholder(s) (if different from 3.):iv | Goldman Sachs International Goldman, Sachs & Co. Goldman Sachs Asset Management, L.P. | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 18 November 2016 | |||
6. Date on which issuer notified: | 22 November 2016 | |||
7. Threshold(s) that is/are crossed orreached: vi, vii | Below 3% | |||
8. Notified details: | ||||||||||||||||||||||||||||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||||||||||||||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||||||||||||||||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||||||||||||||||||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||||||||||||||||||||||||||||
GB0030544687 | 94,532 | 94,532 |
|
| Below 3% |
| Below 3% | |||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||||||||||||||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||||||||||||||||||||||||||||
|
|
| Below 3% | Below 3% | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||
Total (A+B+C) | ||||||||||||||||||||||||||||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||||||||||||||||||||||||||||
Below 3% | Below 3% | |||||||||||||||||||||||||||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
N/A
| ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | N/A | |
11. Number of voting rights proxy holder will ceaseto hold: | N/A | |
12. Date on which proxy holder will cease to holdvoting rights: | N/A | |
| ||
13. Additional information: | General email contact:
| |
14. Contact name: | Joanna Foley | |
15. Contact telephone number: | +44 207 051 9996
| |
Related Shares:
GWP.L